{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:18:31Z","timestamp":1790882311545,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13555-021-00535-7","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T18:03:46Z","timestamp":1620324226000},"page":"1009-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007\u20132018"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4445-965X","authenticated-orcid":false,"given":"Manuel","family":"Batram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2075-323X","authenticated-orcid":false,"given":"Julian","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4850-8597","authenticated-orcid":false,"given":"Magdalena","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-418X","authenticated-orcid":false,"given":"Johannes","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6685-2992","authenticated-orcid":false,"given":"Bernhard","family":"Ultsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-360X","authenticated-orcid":false,"given":"Maren","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-2003","authenticated-orcid":false,"given":"Amit","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-1757","authenticated-orcid":false,"given":"Peter","family":"Wutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Peter","family":"Cri\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-2898","authenticated-orcid":false,"given":"Christiane","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-7150","authenticated-orcid":false,"given":"Klaus","family":"Wahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"F\u00fcchtenbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9552-6969","authenticated-orcid":false,"given":"Wolfgang","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"5","key":"535_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann","year":"2002","unstructured":"Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340\u20136. https:\/\/doi.org\/10.1056\/NEJMcp013211.","journal-title":"N Engl J Med"},{"issue":"3","key":"535_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0025-6196(11)61146-4","volume":"84","author":"P Sampathkumar","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274\u201380. https:\/\/doi.org\/10.1016\/S0025-6196(11)61146-4.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"535_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):9\u201319. https:\/\/doi.org\/10.1111\/jdv.13995.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"535_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jdv.13957","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20\u20139. https:\/\/doi.org\/10.1111\/jdv.13957.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"535_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, Martin M, R\u00e9my V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38\u201347. https:\/\/doi.org\/10.1017\/S0950268808000678.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"535_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in Herpes Zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39(3):342\u20138. https:\/\/doi.org\/10.1086\/421942.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"535_CR7","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1055\/s-0029-1220217","volume":"134","author":"P Wutzler","year":"2009","unstructured":"Wutzler P. Herpes zoster und postherpetische Neuralgie\u2014Vorbeugung durch Impfung? Dtsch Med Wochenschr. 2009;134(Suppl 2):S90\u20134. https:\/\/doi.org\/10.1055\/s-0029-1220217.","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"535_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12879-018-3395-z","volume":"18","author":"D Curran","year":"2018","unstructured":"Curran D, Schmidt-Ott R, Schutter U, Simon J, Anastassopoulou A, Matthews S. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above. BMC Infect Dis. 2018;18(1):496. https:\/\/doi.org\/10.1186\/s12879-018-3395-z.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"535_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, K\u00f6ster I, Reinhold T, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. 2013;14(6):1015\u201326. https:\/\/doi.org\/10.1007\/s10198-012-0452-1.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"535_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J Infect. 2015;70(2):178\u201386. https:\/\/doi.org\/10.1016\/j.jinf.2014.08.018.","journal-title":"J Infect"},{"issue":"1","key":"535_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12879-019-3691-2","volume":"19","author":"M Caputo","year":"2019","unstructured":"Caputo M, Horn J, Karch A, et al. Herpes zoster incidence in Germany\u2014an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort. BMC Infect Dis. 2019;19(1):99. https:\/\/doi.org\/10.1186\/s12879-019-3691-2.","journal-title":"BMC Infect Dis"},{"issue":"10097","key":"535_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(17)31280-1","volume":"390","author":"R Busse","year":"2017","unstructured":"Busse R, Bl\u00fcmel M, Knieps F, B\u00e4rnighausen T. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390(10097):882\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(17)31280-1.","journal-title":"Lancet"},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"g2911","DOI":"10.1136\/bmj.g2911","volume":"348","author":"HJ Forbes","year":"2014","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014;348:g2911. https:\/\/doi.org\/10.1136\/bmj.g2911.","journal-title":"BMJ"},{"issue":"3","key":"535_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/1346-8138.15214","volume":"47","author":"S Imafuku","year":"2020","unstructured":"Imafuku S, Dormal G, Goto Y, J\u00e9gou C, Rosillon D, Matsuki T. Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: results from a claims database cohort study, from 2005 to 2014. J Dermatol. 2020;47(3):236\u201344. https:\/\/doi.org\/10.1111\/1346-8138.15214.","journal-title":"J Dermatol"},{"key":"535_CR15","doi-asserted-by":"publisher","unstructured":"Esteban-Vasallo MD, Dom\u00ednguez-Berj\u00f3n MF, Gil-Prieto R, Astray-Mochales J, Gil de Miguel \u00c1. Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster. Hum Vaccin Immunother 2014; 10(6):1650\u201360. https:\/\/doi.org\/10.4161\/hv.28620.","DOI":"10.4161\/hv.28620"},{"issue":"4","key":"535_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","volume":"42","author":"AP Guignard","year":"2014","unstructured":"Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997\u20132006. Infection. 2014;42(4):729\u201335. https:\/\/doi.org\/10.1007\/s15010-014-0645-x.","journal-title":"Infection"},{"issue":"11","key":"535_CR17","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","volume":"13","author":"C Mu\u00f1oz-Quiles","year":"2017","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, Ampudia-Blasco FJ, D\u00edez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009\u20132014. Hum Vaccin Immunother. 2017;13(11):2606\u201311. https:\/\/doi.org\/10.1080\/21645515.2017.1368600.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"535_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3346\/jkms.2019.34.e1","volume":"34","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Lee CN, Lee MS, et al. Recurrence rate of Herpes Zoster and its risk factors: a population-based cohort study. J Korean Med Sci. 2019;34(2):e1. https:\/\/doi.org\/10.3346\/jkms.2019.34.e1.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"535_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaad.2016.05.037","volume":"75","author":"Y Nakamura","year":"2016","unstructured":"Nakamura Y, Miyagawa F, Okazaki A, et al. Clinical and immunologic features of recurrent herpes zoster (HZ). J Am Acad Dermatol. 2016;75(5):950-956.e1. https:\/\/doi.org\/10.1016\/j.jaad.2016.05.037.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"535_CR20","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.jaad.2016.12.042","volume":"76","author":"JC Pierson","year":"2017","unstructured":"Pierson JC. Reluctance regarding recurrent herpes zoster. J Am Acad Dermatol. 2017;76(4):e143. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.042.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"535_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/s-0034-1396815","volume":"77","author":"E Swart","year":"2015","unstructured":"Swart E, Gothe H, Geyer S, et al. Gute Praxis Sekund\u00e4rdatenanalyse (GPS): Leitlinien und Empfehlungen. Gesundheitswesen. 2015;77(2):120\u20136. https:\/\/doi.org\/10.1055\/s-0034-1396815.","journal-title":"Gesundheitswesen"},{"issue":"8\u20139","key":"535_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.zefq.2014.08.022","volume":"108","author":"E Swart","year":"2014","unstructured":"Swart E, Schmitt J. STandardized Reporting Of Secondary data Analyses (STROSA)\u2014Vorschlag f\u00fcr ein Berichtsformat f\u00fcr Sekund\u00e4rdatenanalysen. Z Evid Fortbild Qual Gesundhwes. 2014;108(8\u20139):511\u20136. https:\/\/doi.org\/10.1016\/j.zefq.2014.08.022.","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"535_CR23","unstructured":"Mitglieder und Versicherte der Gesetzlichen Krankenversicherung (GKV): Statistik \u00fcber Versicherte, gegliedert nach Status, Alter, Wohnort und Kassenart; 2020. https:\/\/www.bundesgesundheitsministerium.de\/themen\/krankenversicherung\/zahlen-und-fakten-zur-krankenversicherung\/mitglieder-und-versicherte.html. Accessed 2 Feb 2021."},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4614-9191-0_5","volume-title":"Health care utilization in Germany: theory, methodology, and results","author":"E Swart","year":"2014","unstructured":"Swart E. Health care utilization research using secondary data. In: Janssen C, Swart E, von Lengerke T, editors. Health care utilization in Germany: theory, methodology, and results. New York: Springer; 2014. p. 63\u20138."},{"key":"535_CR25","unstructured":"Richtlinie des Gemeinsamen Bundesauschusses zur Zusammenf\u00fchrung der Anforderungen an strukturierte Behandlungsprogramme nach \u00a7 137f Absatz 2 SGB V (DMP-Anforderungen-Richtlinie\/DMP-A-RL). https:\/\/www.g-ba.de\/richtlinien\/83\/. Accessed 3 Feb 2021."},{"issue":"3","key":"535_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.healthpol.2016.02.002","volume":"120","author":"L Schang","year":"2016","unstructured":"Schang L, Thomson S, Czypionka T. Explaining differences in stakeholder take up of disease management programmes: a comparative analysis of policy implementation in Austria and Germany. Health Policy. 2016;120(3):281\u201392. https:\/\/doi.org\/10.1016\/j.healthpol.2016.02.002.","journal-title":"Health Policy"},{"issue":"3","key":"535_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00103-019-02882-5","volume":"62","author":"A Siedler","year":"2019","unstructured":"Siedler A, Koch J, Garbe E, et al. Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine: Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019;62(3):352\u201376. https:\/\/doi.org\/10.1007\/s00103-019-02882-5.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"535_CR28","unstructured":"R Core Team. R: A language and environment for statistical computing; 2019. https:\/\/www.R-project.org\/. Accessed 11 Oct 2020."},{"key":"535_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"Categorical data analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A. Categorical data analysis. 2nd ed. Hoboken: Wiley; 2002.","edition":"2"},{"key":"535_CR30","volume-title":"Survival and event history analysis","author":"M Gail","year":"2008","unstructured":"Gail M, Krickeberg K, Samet J, et al. Survival and event history analysis. New York: Springer; 2008."},{"key":"535_CR31","unstructured":"Therneau TM. A package for survival analysis in R: R package version 3.2\u20137; 2020. https:\/\/CRAN.R-project.org\/package=survival. Accessed 14 Dec 2020."},{"key":"535_CR32","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2001","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. 2nd ed. New York: Springer; 2001.","edition":"2"},{"issue":"5","key":"535_CR33","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1503\/cmaj.101137","volume":"183","author":"Y-W Yang","year":"2011","unstructured":"Yang Y-W, Chen Y-H, Wang K-H, Wang C-Y, Lin H-W. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ. 2011;183(5):E275\u201380. https:\/\/doi.org\/10.1503\/cmaj.101137.","journal-title":"CMAJ"},{"issue":"10","key":"535_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.mayocp.2012.05.021","volume":"87","author":"RM Joesoef","year":"2012","unstructured":"Joesoef RM, Harpaz R, Leung J, Bialek SR. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012;87(10):961\u20137. https:\/\/doi.org\/10.1016\/j.mayocp.2012.05.021.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"535_CR35","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.23112","volume":"57","author":"AL Smitten","year":"2007","unstructured":"Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007;57(8):1431\u20138. https:\/\/doi.org\/10.1002\/art.23112.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"535_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/acr.21928","volume":"65","author":"BMA Veetil","year":"2013","unstructured":"Veetil BMA, Myasoedova E, Matteson EL, Gabriel SE, Green AB, Crowson CS. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2013;65(6):854\u201361. https:\/\/doi.org\/10.1002\/acr.21928.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"535_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/02770903.2016.1211142","volume":"54","author":"Y-H Peng","year":"2017","unstructured":"Peng Y-H, Fang H-Y, Wu B-R, et al. Adult asthma is associated with an increased risk of herpes zoster: a population-based cohort study. J Asthma. 2017;54(3):250\u20137. https:\/\/doi.org\/10.1080\/02770903.2016.1211142.","journal-title":"J Asthma"},{"issue":"6","key":"535_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/07853890.2017.1309060","volume":"49","author":"S-J Chen","year":"2017","unstructured":"Chen S-J, Huang K-H, Tsai W-C, Lin C-L, Cheng Y-D, Wei C-C. Asthma status is an independent risk factor for herpes zoster in children: a population-based cohort study. Ann Med. 2017;49(6):504\u201312. https:\/\/doi.org\/10.1080\/07853890.2017.1309060.","journal-title":"Ann Med"},{"issue":"5","key":"535_CR39","doi-asserted-by":"publisher","first-page":"e0155175","DOI":"10.1371\/journal.pone.0155175","volume":"11","author":"H-H Chen","year":"2016","unstructured":"Chen H-H, Lin I-C, Chen H-J, Yeh S-Y, Kao C-H. Association of herpes zoster and type 1 diabetes mellitus. PLoS ONE. 2016;11(5):e0155175. https:\/\/doi.org\/10.1371\/journal.pone.0155175.","journal-title":"PLoS ONE"},{"issue":"6","key":"535_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","volume":"39","author":"A Hata","year":"2011","unstructured":"Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection. 2011;39(6):537\u201344. https:\/\/doi.org\/10.1007\/s15010-011-0162-0.","journal-title":"Infection"},{"key":"535_CR41","doi-asserted-by":"publisher","unstructured":"Lai S-W, Lin C-L, Liao K-F. Real-world database investigating the association between diabetes mellitus and herpes zoster in Taiwan. Medicine (Baltimore) 2019;98(18):e15463.https:\/\/doi.org\/10.1097\/MD.0000000000015463.","DOI":"10.1097\/MD.0000000000015463"},{"issue":"5","key":"535_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jcjd.2017.10.060","volume":"42","author":"JA Queenan","year":"2018","unstructured":"Queenan JA, Farahani P, Ehsani-Moghadam B, Birtwhistle RV. The prevalence and risk for herpes zoster infection in adult patients with diabetes mellitus in the Canadian primary care sentinel surveillance network. Can J Diabetes. 2018;42(5):465\u20139. https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.060.","journal-title":"Can J Diabetes"},{"issue":"3","key":"535_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s15010-007-6347-x","volume":"36","author":"AD Heymann","year":"2008","unstructured":"Heymann AD, Chodick G, Karpati T, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection. 2008;36(3):226\u201330. https:\/\/doi.org\/10.1007\/s15010-007-6347-x.","journal-title":"Infection"},{"issue":"40","key":"535_CR44","doi-asserted-by":"publisher","first-page":"e17430","DOI":"10.1097\/MD.0000000000017430","volume":"98","author":"HG Choi","year":"2019","unstructured":"Choi HG, Kim E-J, Lee YK, Kim M. The risk of herpes zoster virus infection in patients with depression: a longitudinal follow-up study using a national sample cohort. Medicine (Baltimore). 2019;98(40):e17430. https:\/\/doi.org\/10.1097\/MD.0000000000017430.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"535_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcv.2012.06.020","volume":"55","author":"A Lasserre","year":"2012","unstructured":"Lasserre A, Blaizeau F, Gorwood P, et al. Herpes zoster: family history and psychological stress-case-control study. J Clin Virol. 2012;55(2):153\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2012.06.020.","journal-title":"J Clin Virol"},{"issue":"5","key":"535_CR46","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/aje\/kwx338","volume":"187","author":"SAJ Schmidt","year":"2018","unstructured":"Schmidt SAJ, Langan SM, Pedersen HS, et al. Mood disorders and risk of Herpes Zoster in 2 population-based case-control studies in Denmark and the United Kingdom. Am J Epidemiol. 2018;187(5):1019\u201328. https:\/\/doi.org\/10.1093\/aje\/kwx338.","journal-title":"Am J Epidemiol"},{"key":"535_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12879-015-0747-9","volume":"15","author":"P-H Wu","year":"2015","unstructured":"Wu P-H, Lin Y-T, Lin C-Y, Huang M-Y, Chang W-C, Chang W-P. A nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster. BMC Infect Dis. 2015;15:17. https:\/\/doi.org\/10.1186\/s12879-015-0747-9.","journal-title":"BMC Infect Dis"},{"key":"535_CR48","doi-asserted-by":"publisher","unstructured":"Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for Herpes Zoster infection: a meta-analysis. Open Forum Infect Dis 2020; 7(1): ofaa005. https:\/\/doi.org\/10.1093\/ofid\/ofaa005.","DOI":"10.1093\/ofid\/ofaa005"},{"issue":"5","key":"535_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.2010.128637","volume":"70","author":"K Au","year":"2011","unstructured":"Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(5):785\u201391. https:\/\/doi.org\/10.1136\/ard.2010.128637.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"535_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an inter-national, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204223.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"535_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/acr.21812","volume":"65","author":"J Widdifield","year":"2013","unstructured":"Widdifield J, Bernatsky S, Paterson JM, et al. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65(3):353\u201361. https:\/\/doi.org\/10.1002\/acr.21812.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"535_CR52","doi-asserted-by":"publisher","unstructured":"Irwin M, Costlow C, Williams H, et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 1998;178(Supp1):S104\u2013S108. https:\/\/doi.org\/10.1086\/514272.","DOI":"10.1086\/514272"},{"issue":"4","key":"535_CR53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bbi.2011.02.001","volume":"25","author":"MR Irwin","year":"2011","unstructured":"Irwin MR, Levin MJ, Carrillo C, et al. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun. 2011;25(4):759\u201366. https:\/\/doi.org\/10.1016\/j.bbi.2011.02.001.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"535_CR54","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jiz652","volume":"222","author":"HF Tseng","year":"2020","unstructured":"Tseng HF, Bruxvoort K, Ackerson B, et al. The epidemiology of Herpes Zoster in immunocompetent, unvaccinated adults \u226550 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. 2020;222(5):798\u2013806. https:\/\/doi.org\/10.1093\/infdis\/jiz652.","journal-title":"J Infect Dis"},{"key":"535_CR55","doi-asserted-by":"publisher","unstructured":"Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes Zoster and recurrent Herpes Zoster. Open Forum Infect Dis 2017; 4(1): ofx007. https:\/\/doi.org\/10.1093\/ofid\/ofx007.","DOI":"10.1093\/ofid\/ofx007"},{"issue":"2","key":"535_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4065\/mcp.2010.0618","volume":"86","author":"BP Yawn","year":"2011","unstructured":"Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88\u201393. https:\/\/doi.org\/10.4065\/mcp.2010.0618.","journal-title":"Mayo Clin Proc"},{"key":"535_CR57","doi-asserted-by":"publisher","unstructured":"Qian J, Macartney K, Heywood AE, Sheridan S, Liu B. Risk of recurrent herpes zoster in a population-based cohort study of older adults. J Am Acad Dermatol. 2020;127(3):314\u201330.  https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1013.","DOI":"10.1016\/j.jaad.2020.06.1013"},{"issue":"1","key":"535_CR58","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12879-020-05648-6","volume":"20","author":"C Mu\u00f1oz-Quiles","year":"2020","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, D\u00edez-Domingo J, Orrico-S\u00e1nchez A. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009\u20132014. BMC Infect Dis. 2020;20(1):905. https:\/\/doi.org\/10.1186\/s12879-020-05648-6.","journal-title":"BMC Infect Dis"},{"key":"535_CR59","unstructured":"Erler A. Garbage in Garbage out? Morbidit\u00e4tsorientierte Regelleistungsvolumina und Validit\u00e4t von Abrechnungsdiagnosen in haus\u00e4rztlichen Praxen; 2007. https:\/\/refubium.fu-berlin.de\/handle\/fub188\/7236. Accessed 14 Oct 2020."},{"key":"535_CR60","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. Nutzung von BARMER-Versorgungsdaten im Verfahren der Dossierbewertung des IQWiG; 2020. https:\/\/www.iqwig.de\/projekte\/ga17-04.html. Accessed 14 Oct 2020."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00535-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T06:58:43Z","timestamp":1622185123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00535-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00535-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"14 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}